Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
Edeline J, Touchefeu Y, Guiu B, Farge O, Tougeron D, Baumgaertner I, Ayav A, Campillo-Gimenez B, Beuzit L, Pracht M, Lièvre A, Le Sourd S, Boudjema K, Rolland Y, Boucher E, Garin E. Edeline J, et al. Among authors: beuzit l. JAMA Oncol. 2020 Jan 1;6(1):51-59. doi: 10.1001/jamaoncol.2019.3702. JAMA Oncol. 2020. PMID: 31670746 Free PMC article. Clinical Trial.
Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT).
Beuzit L, Edeline J, Brun V, Ronot M, Guillygomarc'h A, Boudjema K, Gandon Y, Garin E, Rolland Y. Beuzit L, et al. Eur J Radiol. 2016 Aug;85(8):1445-52. doi: 10.1016/j.ejrad.2016.05.020. Epub 2016 Jun 2. Eur J Radiol. 2016. PMID: 27423686 Free article.
Selective Internal Radiation Combined with Chemotherapy Maintains the Quality of Life in Intrahepatic Cholangiocarcinomas.
Goislard de Monsabert C, Touchefeu Y, Guiu B, Campillo-Gimenez B, Farges O, Tougeron D, Baumgaertner I, Ayav A, Beuzit L, Pracht M, Lièvre A, Le Sourd S, Boudjema K, Rolland Y, Garin E, Boucher E, Edeline J. Goislard de Monsabert C, et al. Among authors: beuzit l. Curr Oncol. 2021 Nov 8;28(6):4530-4541. doi: 10.3390/curroncol28060384. Curr Oncol. 2021. PMID: 34898592 Free PMC article.
Comparison of 18F-Choline PET/CT and MRI functional parameters in prostate cancer.
Palard-Novello X, Beuzit L, Gambarota G, Le Jeune F, Garin E, Salaün PY, Devillers A, Querellou S, Bourguet P, Saint-Jalmes H. Palard-Novello X, et al. Among authors: beuzit l. Ann Nucl Med. 2019 Jan;33(1):47-54. doi: 10.1007/s12149-018-1302-8. Epub 2018 Sep 15. Ann Nucl Med. 2019. PMID: 30219990
Complete Transurethral Resection before Radical Cystectomy May Improve Oncological Outcomes.
Graffeille V, Verhoest G, Gryn A, Kammerer-Jacquet SF, Alimi Q, Beauval JB, Beuzit L, Pradère B, Thoulouzan M, Khene ZE, Guille F, Rioux-Leclercq N, Mathieu R, Gamé X, Bensalah K, Soulié M, Roumiguié M, Peyronnet B. Graffeille V, et al. Among authors: beuzit l. Urol Int. 2022;106(2):122-129. doi: 10.1159/000512053. Epub 2021 Feb 24. Urol Int. 2022. PMID: 33626547
Percutaneous Ablation Versus Surgical Resection for Local Recurrence Following Partial Nephrectomy for Renal Cell Cancer: A Propensity Score Analysis (REPART Study-UroCCR 71).
Brassier M, Khene ZE, Bernhard JC, Dang VT, Ouzaid I, Nouhaud FX, Olivier J, Nedelcu C, Grenier N, Beuzit L, Doumerc N, Bensalah K, Bigot P; Members of the French Committee of Urologic Oncology. Brassier M, et al. Among authors: beuzit l. Eur Urol Focus. 2022 Jan;8(1):210-216. doi: 10.1016/j.euf.2021.02.007. Epub 2021 Feb 20. Eur Urol Focus. 2022. PMID: 33622625
15 results